BACKGROUND: Th ere are few data regarding mechanical ventilation and ARDS in the ED. Th is could be a vital arena for prevention and treatment.
The frequency of critically ill patients in the ED and the severity of illness have increased. 1 The need for mechanical ventilation is one of the most common indications for ICU admission and has also increased in incidence. 2, 3 Initiation of mechanical ventilation in the ED is common, and because of the long ED length of stays (LOSs) for critically ill patients, mechanical ventilation hours provided have also increased. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Despite these trends, there remain relatively few data on ED-based mechanical ventilation practices. 14 ARDS exacts a signifi cant toll on patients who are mechanically ventilated in terms of mortality, long-term survivor morbidity, and health-care use. 15, 16 Compared with those in the ICU, ARDS data in the ED population are sparse. Th e ED prevalence of ARDS and knowledge of the early factors that may promote its development and modify its severity are incomplete. Observational studies indicate an ARDS prevalence of approximately 9% in patients receiving mechanical ventilation in the ED. 14, 17, 18 Most of these data, however, are restricted to a narrow cohort of patients (ie, those with sepsis) and are singlecenter investigations.
In patients with ARDS, unequivocal data exist that harmful ventilator settings cause ventilator-associated lung injury (VALI) and worsen outcome. [19] [20] [21] In patients without ARDS but at risk of the syndrome, there are mounting data to suggest that the mechanical ventilator contributes to ARDS development. [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] Most relevant to the ED, the pathophysiology triggered by VALI can occur within hours, and progression to ARDS in at-risk patients typically occurs shortly aft er admission. 29, [32] [33] [34] [35] We hypothesize that modifi able patient characteristics and treatment variables can infl uence clinical outcome during this most proximal time window. In the future, the ED could, therefore, be a vital arena for the treatment and clinical investigation of patients who are mechanically ventilated to (1) further refi ne predictive variables of outcome, (2) improve the quality of mechanical ventilation delivered during the early stages of respiratory failure, (3) decrease the incidence of ARDS, and (4) decrease mortality and long-term survivor morbidity.
Th e objectives of this study were to (1) further characterize ED mechanical ventilation practices, (2) determine the incidence of ARDS aft er admission and the risk factors associated with this outcome, (3) determine the prevalence of ARDS in the ED and assess ED compliance with lung-protective ventilation, and (4) assess outcome diff erences between patients with ARDS and those without ARDS.
Materials and Methods
Th is was a multicenter, prospective, observational, cross-sectional study conducted at four academic EDs. For each center, data were collected during four temporally distinct 1-month time periods (July 10, 2012, to August 10, 2012; September 1, 2012, to October 2, 2012; January 21, 2013, to February 22, 2013; and July 2, 2013, to August 3, 2013) . Th e study, therefore, spanned a total of 13 months. Th is observational study is reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. 36 Th e institutional review boards at each site approved the study under waiver of informed consent ( e-Appendix 1 ).
Eligible patients were all patients receiving mechanical ventilation in the ED and aged Ն 18 years. Exclusion criteria were as follows: (1) death in the ED, (2) ED LOS , 1 h, (3) total mechanical ventilation duration , 1 h, and (4) elective extubation while in the ED. To ensure uniform data collection and accuracy, all variables were defi ned a priori and were recorded in a standardized format during the data collection process.
The baseline patient characteristics included age, sex, race, weight, height, predicted body weight (PBW), BMI, ED LOS, patient comorbidities, home medications, vital signs, hemodynamics, and laboratory values. Modifi ed APACHE (Acute Physiology and Chronic Health Evaluation) II and Sequential Organ Failure Assessment (SOFA) scores and the Lung Injury Prediction Score (LIPS) were determined. 37-41 PBW in kilograms was calculated according to the following formula: men, 50 1 2.3 (height [inches] -60); women, 45.5 1 2.3 (height [inches] -60). 42 Process of care variables in the ED (IV fl uid, blood products, etc) were collected, as were all ventilator-related variables. All these data were collected prospectively by research assistants and principal investigators (PIs) at each site.
Defi nitions
Definitions of comorbid conditions are provided in e-Appendix 2 . Severe sepsis and septic shock were defi ned as described previously. 43, 44 Lung-protective ventilation was defined as the use of tidal volume of , 8 mL/kg PBW, because this was the upper limit of tidal volume allowed by previous investigations of low tidal volume ventilation in ARDS. 19 We did not include a pressure limit to defi ne lung protective, because previous data suggest monitoring of inspiratory plateau pressure is rare in intubated patients in the ED. 14 
Outcomes
All patients were analyzed for ED mechanical ventilation practices. Th e primary outcome variable of interest was the development of ARDS aft er admission, and it was defined according to the Berlin definition. 45 It was assessed by site PIs at least once daily (based on frequency of chest radiographs and arterial blood gas measurements). Given the focus of this investigation on ED-based factors associated with ARDS development, and data suggesting that the majority of ARDS cases develop in the fi rst 5 days aft er admission, assessment of the primary outcome was 10 .1378/chest. restricted to day 5 aft er ICU admission (or death if occurring prior to day 5). 40 In patients without an arterial blood gas measurement, the oxygenation criteria was determined using the pulse oximeter to F io 2 ratio as described previously. 46 When more than one value was present, the worst value was selected.
A detailed description of our standard operating procedure for adjudicating ARDS status is provided in e-Appendix 3 . Secondary analyses of interest included clinical outcome diff erences between patients with ARDS and those without ARDS. Th ese outcomes were assessed daily by research assistants and site PIs until hospital discharge.
Analysis
Descriptive statistics, including mean Ϯ SD, median (interquartile range [IQR]), and frequency distributions were used to assess the characteristics of the patient cohort. Th e Spearman correlation coeffi cient ( r ) was used to assess the relationship between ED and ICU tidal volume. To assess predictors of progression to ARDS, continuous and categorical variables were compared using an unpaired t test, Wilcoxon test, x 2 test, or Fisher exact test, as appropriate. Variables that were statistically signifi cant in univariate analyses at a P Յ .10 level were candidates for inclusion in a bidirectional, stepwise, multivariable logistic regression analysis. Th e stepwise regression method selected variables for inclusion or exclusion from the model in a sequential fashion based on the significance level of .10 for entry and .15 for removal. Statistical interactions and collinearity were assessed. Th e model used variables that contributed information that was statistically independent of the other variables in the model. Th e model's goodness of fi t was assessed with the Hosmer-Lemeshow test. Adjusted ORs and corresponding 95% CIs are reported for variables in the multivariable model, adjusted for all variables in the model. To assess clinical outcomes based on ARDS status, x 2 and Kruskal-Wallis tests were used to compare groups. Th e Kaplan-Meier method was used to compare mortality diff erence. All tests were two-tailed, and a P value , .05 was considered statistically signifi cant. A sample size calculation was not performed a priori, because the primary analysis was descriptive and was to further characterize mechanical ventilation in the ED. Based on previous existing data, our sample size was recognized as likely to be adequate for investigation of ED-based parameters associated with progression to ARDS. 14, 47 Th e analysis was conducted in consultation with a biostatistician.
Results

Characteristics of Study Subjects
A total of 259 patients received mechanical ventilation in the ED during the study period ( Fig 1 ) ; the fi nal study population totaled 219 patients. All patients were assessed for mechanical ventilation practices and clinical outcomes. Fift een patients (6.8%) had ARDS while in the ED and were excluded from the analysis of risk factors for ARDS progression aft er ED admission. Table 1 shows the baseline characteristics of the study popula-tion. For the entire cohort, the median ED LOS was 3.4 h (IQR, 2.2-5.4 h), with a range of 1.1 to 18.3 h.
Ventilator Characteristics
Ventilator variables are presented in Table 2 . Th e preferred mode of ventilation across centers was assist-control, volume-control ventilation (65.3%). Th e median tidal vol ume delivered was 7.6 mL/kg PBW (IQR, 6.9-8.9 mL/kg PBW), with a range of 4.3-12.2 mL/kg PBW. Figure 2 shows the distribution of tidal volume in the ED. Lungprotective ventilation was used in 122 patients (55.7%), and 25 patients (11.4%) were ventilated with a tidal volume . 10 mL/kg PBW. Of the 97 patients ventilated with non-lung-protective ventilation in the ED, 31 (32%) had their settings changed to protective settings upon ICU arrival. ED tidal volume was signifi cantly correlated to ICU tidal volume ( r s 5 0.60, P , .001 ).
In the subgroup of patients exposed to non-lungprotective ventilator while in the ED, ED tidal volume remained signifi cantly correlated to ICU tidal volume ( r s 5 0.46, P , .001). Inspiratory plateau pressure was recorded in 78 patients (35.6%). At least one ventilator parameter was changed in 150 patients (68.5%) during their ED stay. Th e head of bed was elevated in 79 patients (36.1%) while receiving mechanical ventilation in the ED.
Analysis of ARDS
Th e incidence of ARDS aft er admission from the ED was 14.7% (n 5 30), with a mean Ϯ SD onset of 2.3 Ϯ 1.2 days ( Fig 3 ) . Th ere were no diff erences in the ED ventilator variables in these patients ( Table 2 ) . Multivariable logistic regression analysis demonstrated that higher ED APACHE II scores and LIPS were associated with progression to ARDS, as was a higher SOFA score (persistent organ failure) on ICU day 2. Intubation occurring prehospital or from a transferring facility was associated with an increased risk of ARDS compared with ED intubation ( Table 3 ) .
Fift een patients (6.8%) had ARDS during their stay in the ED. Median tidal volume was 8.2 mL/kg PBW (IQR, 7.2-9.0 mL/kg PBW), compared with 7.6 mL/kg PBW (IQR, 6.9-8.9 mL/kg PBW) in patients without ARDS ( P 5 .37). Lung-protective ventilation was used in seven patients with ARDS (46.7%). Inspiratory plateau Table 4 ).
Discussion
Our fi rst objective was to characterize further the use of mechanical ventilation in the ED across a heterogeneous patient population in multiple centers. To summarize, based on our analysis, mechanical ventilation in the ED is delivered using (1) higher than recommended tidal volumes and infrequent lung-protective ventilation regardless of ARDS status, (2) high F io 2 ranging as high as 14.6 mL/kg PBW. 14 The current investigation shows a decrease of about 1 mL/kg PBW and overall less variability in practice. However, a signifi cant percentage of patients remain exposed to high tidal volumes while in the ED. Based on three systematic reviews and meta-analyses, non-lung-protective ventilation seems to be associated with VALI and the development of ARDS. 29, 31, 48 Our results highlight the infrequency with which positive end-expiratory pressure is titrated in the ED, in favor of delivery of high levels of oxygen. Increasing evidence suggests excessive oxygen exposure has adverse eff ects in various conditions, such as cardiac arrest, ARDS, COPD, and acute myocardial infarction. [49] [50] [51] [52] [53] Providing an optimal environment for lung protection, however, probably requires attention to not only tidal volume, but also appropriate lung recruitment and oxygen exposure. Variables are reported as mean Ϯ SD unless indicated otherwise. D refers to the change in SOFA score from ED baseline to 48 h. A negative value refl ects an improvement in organ function. HLOS 5 hospital length of stay. See Table 1 for expansion of other abbreviations.
Only one-third of the study cohort had their head of bed elevated while undergoing mechanical ventilation in the ED. Supine head position during the fi rst 24 h of mechanical ventilation is an independent risk factor for pneumonia. 54 Th is is an immediately modifi able process of care variable that could reduce complications in patients receiving mechanical ventilation admitted from the ED.
Prior work showed an ARDS prevalence of 8.8% in patients receiving mechanical ventilation with severe sepsis in the ED and septic shock. 14 Th is current investigation of a heterogeneous ED population demonstrated an ARDS prevalence of 6.8%, which is similar to the fi ndings of work examining ARDS in patients receiving mechanical ventilation in the ED. 14, 17, 18 Combining data from these studies provides some epidemiologic insight into an ED ARDS prevalence of approximately 8.4% in intubated patients. As in previous work, adherence to lung-protective ventilation in patients with ARDS was low (46.7%). With a conservative estimate of 240,000 patients who receive ED mechanical ventilation annually, the sheer number of patients exposed to potentially harmful ventilation presents an opportunity to reexamine clinical practice and to study these patients further. 6 VALI and ARDS can evolve quickly. 22, 24, 26, 32, 33, 47, 55, 56 Th e ED represents a period of early critical illness during which protective interventions can infl uence the complications of critical illness. 57 However, our data cannot answer the question of whether altering ED ventilator practices will decrease ARDS or mitigate its severity, and our study did not show any association with ventilator variables and incidence of ARDS. 57, 58 Th is may indicate that our study was underpowered to detect a small diff erence that does exist, that there is a true lack of association between ED ventilator management and downstream complications, or that the ED exposure is too short to impact the outcome. However, our data do suggest that ED tidal volume settings infl uence those delivered in the ICU. Th is remained true for patients exposed to nonlung-protective ventilation in the ED and suggests that even suboptimal ventilator settings were continued forth into early ICU care. Furthermore, although tidal volume oft en exceeded 8 mL/kg PBW, rarely did it exceed the levels shown in prior trials to be injurious in patients with established ARDS (ie, 12 mL/kg PBW) or at risk of the syndrome (ie, 10 mL/kg PBW [11.4% of patients in this study]). 19, 25 Th erefore, in a study of this size, deviations of this magnitude may not be enough to cause a measurable clinical diff erence, both in terms of ARDS mortality and ARDS development. A lack of association between ventilator variables and ARDS incidence may also refl ect the fact that the cause of ARDS is heterogeneous; the most appropriate ED intervention may be a bundled, quality-based approach to address ventilator and nonventilator treatments. 57 Th e incidence of ARDS development in this heterogeneous cohort was 14.7%; a previous investigation of patients with severe sepsis and septic shock (perhaps the highest risk cohort for ARDS) showed an ARDS incidence of 27.5% aft er ED admission. 14 Th is provides further evidence that ARDS prevention strategies should be considered a priority in emergency research and quality initiatives. Clinical ARDS research has historically been confi ned to the ICU, but as additional preventive therapies are proposed, ED-based trials will be critical to treat high-risk patients early in the course of disease. Th e results of our multivariable analysis coincide with the fi ndings of prior research and suggest that these high-risk patients are identifi ed by higher illness severity scores (APACHE II) and LIPS. 40 Our results also suggest that two potential non-ventilator-related variables could be targets for future ARDS prevention: reversal of early organ failure and prehospital intubation.
Th is study has important limitations. Th is was a crosssectional study conducted over a single time period (ie, 1 month) at each center. ED mechanical ventilation practice patterns and incidence of ARDS may vary in association with seasonal respiratory illnesses such as H1N1 infl uenza. However, there is a lack of data to support seasonal variation of ARDS, and our study months were temporally distinct and varied seasonally across centers. Th is temporal distribution off ers some assurance that our data represent a national longitudinal sample. 59 Th is was a relatively small study and, therefore, prone to random error. However, our results are consistent with prior evidence. Th is study was restricted to academic medical centers. It is, therefore, possible that these data are not truly representative of ED-based mechanical ventilation practices and ARDS prevalence in the community as a whole. Th e multicenter trial design, consistency with the small amount of previously published data, and inclusion of all mechanically ventilated patients do improve the external validity of our results.
Adjudicating ARDS status can be diffi cult and will always have a subjective component. Th is potentially exposes the study to ascertainment bias. Our adjudication protocol was systematic, rigorous, and objective. Our event rate for ARDS was also consistent with that of Financial/nonfi nancial disclosures : Th e authors have reported to CHEST that no potential confl icts of interest exist with any companies/organizations whose products or services may be discussed in this article.
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Finally, the trained research assistants played no role in the clinical care of the patients, and the physicians were unaware of our study hypotheses. However, the possibility that the presence of bedside research assistants infl uenced clinical care and ventilator settings cannot be excluded completely (ie, Hawthorne-like eff ect). Our fi ndings, particularly suboptimal adherence to best-practice guidelines such as protective lung ventilation strategies and head-of-bed elevation, speak against this possibility.
Conclusions
Th is multicenter study of patients with respiratory failure in the ED demonstrates a signifi cant opportunity to improve ED-based mechanical ventilation practices. Th is includes delivery of lung-protective ventilation, monitoring of inspiratory plateau pressure, and headof-bed elevation. Across a heterogeneous intubated population in the ED, progression to ARDS is a common occurrence, occurs early aft er ICU admission, and leads to signifi cant negative clinical consequences. Modifi able patient-and treatment-related variables exist that could prevent or mitigate ARDS severity, and the ED and prehospital environments should be investigated further.
